search
Back to results

Topical Analgesia for Pain Relief in Hysterosalpingography (HSG)

Primary Purpose

Infertility, Female

Status
Completed
Phase
Not Applicable
Locations
Nigeria
Study Type
Interventional
Intervention
Lidocaine Gel
KY jelly
Sponsored by
Ahmadu Bello University Teaching Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Infertility, Female focused on measuring infertility, hysterosalpingography, pain

Eligibility Criteria

18 Years - 49 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • All women that are sent in to the department of radiology for Hysterosalpingogram as part of evaluation for infertility that give consent.

Exclusion Criteria:

  • Women that present for hysterosalpingography for other indications apart from infertility and those that have history of allergy to xylocaine and/or K-Y jelly.

Sites / Locations

  • Ahmadu Bello University Teaching Hospital Shika-Zaria

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Study Group

Control group

Arm Description

15g of Topical Xylocaine gel

15g of KY Jelly

Outcomes

Primary Outcome Measures

Pain perception
The pain score based on visual pain scale that assesses pain perception. It is a scale of 0 to 10. 0 = absence of pain. = discomfort = mild pain. = annoying pain. = nagging pain. = distressing pain. = miserable. = intense = Dreadful. = worse possible = unbearable

Secondary Outcome Measures

Patients Satisfaction with procedure
Satisfaction with the procedure based on Likert scale. The scale is from 1 to 5. = Very dissatisfied. = Dissatisfied.. = Neither satisfied nor dissatisfied. = Satisfied. = Very satisfied.

Full Information

First Posted
January 10, 2019
Last Updated
August 14, 2020
Sponsor
Ahmadu Bello University Teaching Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03802032
Brief Title
Topical Analgesia for Pain Relief in Hysterosalpingography
Acronym
HSG
Official Title
Effect of Topical Xylocaine for Pain Relief During Hysterosalpingography Among Infertile Women in Zaria, Nigeria: A Randomised Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
August 2020
Overall Recruitment Status
Completed
Study Start Date
February 1, 2019 (Actual)
Primary Completion Date
December 22, 2019 (Actual)
Study Completion Date
December 22, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ahmadu Bello University Teaching Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The study will involve giving topical analgesia or placebo and then assessing pain and satisfaction during and after the procedure in order to see wed to the placebo.hether the topical analgesia has helped in decreasing pain associated with the procedure and also whether it has increasedd satisfaction with the procedure compar
Detailed Description
STUDY DESIGN: The study will be a double blind randomized controlled trial. Group A:The study group will be given topical Xylocaine (2% Lidocaine) before the procedure. Group B:The control group will be given topical K-Y jelly (water based lubricant) before the procedure. The participants and the radiologist will be blinded at the point of drug administration. SAMPLE SIZE DETERMINATION: The formula below was used to calculate the sample size n= (Zα + Zβ)2S2 d2 Assuming a difference in mean pain score among groups of 1.5 and using a standard deviation of of 3.15. Zα = standard normal deviate. Zβ = power = 95% = 1.64. S = standard deviation = 3.1. D = mean difference in pain score = 1.5 n = (1.96 + 1.64)2 x 3.12 1.52 n = 55 Sample size per group will be rounded up to 60 SAMPLING APPROACH: A probability sampling method will be used. Simple random sampling using a computer generated table of random numbers will be used. The WINPEPI version 11.65 software will generate the table of random numbers. The numbers 001-140 will be randomly allocated to two groups A and B. Group A will be the study group and group B will be the control group (see appendix). Each number from the table of random numbers will be copied on separate paper and then sealed in a brown envelope. The envelopes will then be kept inside a box after shuffling. Each patient will be allocated to the group that the number she picks corresponds to on the computer printout. The numbers were made up to 140 to make up for patients that may eventually drop out from the study. . SAMPLING RECRUITEMENT: Women that fulfil the inclusion criteria will be recruited from radiology department as they present for Hysterosalpingogram. After obtaining a written consent, participants will be requested to pick one of the brown envelopes which will contain the randomization group. BLINDING The drugs to be used (K-Y Jelly and Xylocaine gel) are identical. DATA COLLECTION METHOD: An informed written consent will be obtained from participants. Psychological support will be given to the participant by a nurse after the procedure has been explained to the participant. A questionnaire will then be filled. The participant will then be requested to pick an envelope that represents the study number. A detailed explanation about the VAS and its application was given personally to each woman before the procedure. An interviewer administered questionnaire will be used to obtain information on socio-demographic characteristics, reproductive profile, previous history of the procedure and experience with analgesia. The analgesic or placebo will be applied to the cervix (15ml) using a vaginal applicator 10 minutes before the procedure. The procedure will then be done using standard clinical protocol. The pain rating scale will be used to evaluate pain during from zero (no pain) to ten (worst possible pain) will be explained to the client. The visual scale comparison to happy, glum, sad and horrified faces will also be explained to the patient. Pain assessment will be done during the procedure at the following steps: After application of speculum. After cervical manipulation (application of tenaculum and catheter). After filling the uterus with contrast medium. After withdrawal of speculum and catheter. Thirty minutes after completing the procedure. The Likert scale will be used to assess patient satisfaction following pain management. .

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertility, Female
Keywords
infertility, hysterosalpingography, pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A randomised controlled trial
Masking
Care Provider
Masking Description
Double blind
Allocation
Randomized
Enrollment
120 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Study Group
Arm Type
Experimental
Arm Description
15g of Topical Xylocaine gel
Arm Title
Control group
Arm Type
Placebo Comparator
Arm Description
15g of KY Jelly
Intervention Type
Drug
Intervention Name(s)
Lidocaine Gel
Intervention Description
topical lidocaine gel
Intervention Type
Drug
Intervention Name(s)
KY jelly
Intervention Description
topical KY jelly
Primary Outcome Measure Information:
Title
Pain perception
Description
The pain score based on visual pain scale that assesses pain perception. It is a scale of 0 to 10. 0 = absence of pain. = discomfort = mild pain. = annoying pain. = nagging pain. = distressing pain. = miserable. = intense = Dreadful. = worse possible = unbearable
Time Frame
witthin 45 minutes of the procedure
Secondary Outcome Measure Information:
Title
Patients Satisfaction with procedure
Description
Satisfaction with the procedure based on Likert scale. The scale is from 1 to 5. = Very dissatisfied. = Dissatisfied.. = Neither satisfied nor dissatisfied. = Satisfied. = Very satisfied.
Time Frame
witthin 45 minutes of the procedure

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
based on biological gender
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
49 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: All women that are sent in to the department of radiology for Hysterosalpingogram as part of evaluation for infertility that give consent. Exclusion Criteria: Women that present for hysterosalpingography for other indications apart from infertility and those that have history of allergy to xylocaine and/or K-Y jelly.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anisah Yahya, MBBS
Organizational Affiliation
Ahmadu Bello University Zaria
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ahmadu Bello University Teaching Hospital Shika-Zaria
City
Zaria
State/Province
Kaduna
ZIP/Postal Code
PMB 06
Country
Nigeria

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
obtained data and result will be shared
IPD Sharing Time Frame
within 6 months of completion
IPD Sharing Access Criteria
free

Learn more about this trial

Topical Analgesia for Pain Relief in Hysterosalpingography

We'll reach out to this number within 24 hrs